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ABSTRACT 
Psoriasis is one of the most common skin diseases, affecting 2–5% of the world's population. 
It is a skin autoimmune disorder, resulting in an excessive growth and aberrant differentiation 
of keratinocytes. Psoriasis is an incurable lifetime disease which can only be controlled and 
relieved through medication. Various approaches have been explored to treat the disease. 
Treatment of psoriasis includes topical therapy, systemic therapy and phototherapy. Topical 
therapy is the first line treatment and it is the most practical medication method for psoriasis 
patients. However, the conventional topical treatments such as gel and cream have low 
efficiency, poor cosmetic and aesthetic appeal, leading to poor patient compliance or 
adherence, while systemic and photo therapy produce significant adverse side effects. 
Nanoemulsion is defined as an emulsion system consisting of oil, surfactant, and water with 
an isotropic, transparent (or translucent) appearance. The emulsion droplet size is defined to 
be less than 200 nm. Nonetheless, if the emulsion has low surfactant content and is 
kinetically stable, a size of less than 500 nm can be accepted as nanoemulsion. A small 
droplet size would enhance the delivery and penetration of a drug through the psoriasis skin 
layer. There has been a growing interest in using nanoemulsions in topical applications, due 
to their high stability and their optical transparency or translucency, which make them good 
and very dermatologically attractive. A good selection of oils and surfactants would enhance 
the transdermal treatment efficacy. This review highlights the potential of drug-loaded 
nanoemulsions for the treatment of psoriasis towards achieving better efficacy and 
eliminating side effects. 
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